Need help finding what you are looking for?
Contact Us
PUBLISHER: Lucintel | PRODUCT CODE: 1894061
PUBLISHER: Lucintel | PRODUCT CODE: 1894061
In-Silico Drug Discovery Market Report: Trends, Forecast and Competitive Analysis to 2031
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 3 business days
SELECT AN OPTION
The future of the global in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets. The global in-silico drug discovery market is expected to reach an estimated $6.1 billion by 2031 with a CAGR of 10.2% from 2025 to 2031. The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.
- Lucintel forecasts that, within the type category, software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.
- Within the end use category, pharmaceutical industry will remain the largest segment due as in-silico drug discovery helps the pharmaceutical companies to reduce the time and cost of developing new drugs.
- In terms of regions, North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of market players, and large patient population suffering from various chronic and infectious diseases in the region.
Emerging Trends in the In-Silico Drug Discovery Market
There are several emerging trends in the in-silico drug discovery market that mark the changing face of drug development and research.
- AI and Machine Learning Integration: Artificial intelligence and machine learning are increasingly integrated into drug development processes, enhancing predictive accuracy and optimizing drug design. These technologies analyze large datasets to predict drug interactions with greater precision.
- Personalized Medicine: Advances in genomics and bioinformatics drive interest in personalized medicine. In-silico models tailored to individual genetic profiles improve efficacy and reduce adverse effects.
- Cloud-Based Platforms: Cloud-based platforms are gaining popularity due to their scalable delivery of in-silico drug discovery solutions. These platforms facilitate collaboration, data sharing, and computational analysis, streamlining drug discovery.
- High-Performance Computing: The use of high-performance computing is expanding, allowing complex simulations and large-scale data analysis. This enables more detailed in-silico modeling, accelerating drug discovery.
- Multi-Omics Data Integration: The integration of multi-omics data, including genomics, proteomics, and metabolomics, is advancing in in-silico drug discovery. This approach provides a deeper understanding of biological systems and aids in identifying potential drug targets.
These trends continue to reshape the in-silico drug discovery market by advancing the technological capabilities, precision, and efficiency of drug discovery processes.
Recent Developments in the In-Silico Drug Discovery Market
Recent developments in the in-silico drug discovery market show significant advancement and innovation, contributing to growth in drug discovery methodologies.
- AI Algorithm Development: New machine learning algorithms improve predictive modeling and virtual screening, accelerating the identification of drug candidates and the overall drug discovery process.
- Genomic Data Integration: Incorporating genomic data enhances the precision of in-silico models for drug target identification and personalized medicine, aiding in the development of therapies based on genetic information.
- Growth of Cloud-Based Solutions: Cloud-based solutions are now common, providing scalable and flexible platforms for in-silico drug discovery. These solutions support collaboration through data sharing among researchers and pharmaceutical companies.
- High-Performance Computing Improvements: Advances in high-performance computing enable complex simulations and data analysis, supporting detailed in-silico modeling and expediting drug development.
- Multi-Omics Integration Tools: Tools for integrating multi-omics data are rapidly improving, offering comprehensive insights into biological systems. This development enhances drug target identification and supports effective therapy development.
These factors are shaping the in-silico drug discovery market by improving technological capabilities, increasing applications, and accelerating drug discovery.
Strategic Growth Opportunities in the In-Silico Drug Discovery Market
The in-silico drug discovery market presents various strategic growth opportunities across key applications. Identifying and leveraging these opportunities will drive further expansion and innovation in the market.
- AI-Driven Drug Discovery: Developing AI-driven platforms enhances predictive modeling and virtual screening, making drug discovery more efficient and reducing development costs.
- Personalized Medicine Solutions: There is growth in developing in-silico models for personalized medicine. Companies can improve treatment efficacy by tailoring drug discovery to individual genetic profiles.
- Cloud-Based Drug Discovery Platforms: The growth of cloud-based platforms provides scalable and accessible drug discovery solutions, supporting global collaboration and data sharing among research teams.
- High-Performance Computing Services: High-performance computing addresses the need for complex simulations and large-scale data analysis in drug discovery, supporting extensive in-silico modeling and expediting drug development.
- Multi-Omics Integration Technologies: Investment in multi-omics integration technologies enhances drug target identification and development by providing a more comprehensive understanding of biological systems.
These opportunities will drive growth in the in-silico drug discovery market by advancing technological capabilities, expanding services, and fostering innovation in drug development.
In-Silico Drug Discovery Market Driver and Challenges
The in-silico drug discovery market is constantly shaped by technology, economics, and regulatory factors. This section outlines the key drivers and challenges in the market and ways to address them.
The factors driving the in-silico drug discovery market include:
- Technological advancements: Innovations in AI, machine learning, and high-performance computing strongly drive growth in in-silico drug discovery. These technologies improve predictive accuracy and streamline drug discovery processes.
- Increasing R&D investment: Growing investment in research and development supports the development of new tools and technologies, thereby enhancing efficiency in drug discovery.
- Demand for personalized medicine: Personalized medicine encourages the use of in-silico models that tailor drug discovery to an individual's genetic makeup, offering better treatment with fewer side effects.
- Cloud adoption: Expanding cloud computing enables access to scalable and flexible platforms for drug discovery. Cloud-based solutions support collaboration, data sharing, and computational analysis.
- Integration of multi-omics data: Integrating multi-omics data allows in-silico drug discovery to achieve a holistic understanding of biological systems, improving the accuracy of drug target identification and development.
Challenges in the in-silico drug discovery market include:
- Data privacy and security: Ensuring the privacy and security of sensitive data is a key challenge. Protecting intellectual property and patient data is essential for building trust and ensuring compliance.
- Complexity of integration: Integrating various data sources and technologies into cohesive in-silico models presents a complex challenge. Compatibility issues must be addressed to create a seamless flow of data.
- High costs of advanced technologies: The substantial costs of advanced technologies and computational resources can be a significant obstacle for organizations, impacting the cost-benefit balance in in-silico drug discovery.
These drivers and challenges shape the in-silico drug discovery market, influencing growth, innovation, and overall market dynamics.
List of In-Silico Drug Discovery Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies in-silico drug discovery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-silico drug discovery companies profiled in this report include-
- Curia
- Certara
- Charles River Laboratories
- Chemical Computing
- GenScript
- Sygnature Discovery
- Abzena
In-Silico Drug Discovery by Segment
The study includes a forecast for the global in-silico drug discovery by type, target therapeutic area, workflow, end use, and region.
In-Silico Drug Discovery Market by Type [Analysis by Value from 2019 to 2031]:
- Software as a service
- Consultancy as a service
- Software
In-Silico Drug Discovery Market by Target Therapeutic Area [Analysis by Value from 2019 to 2031]:
- Human Immunodeficiency Virus (HIV)
- Infectious diseases
- Metabolic disorders
- Mental disorders
- Musculoskeletal disorders
- Neurological disorders
- Oncological disorders
- Respiratory disorders
- Others
In-Silico Drug Discovery Market by Workflow [Analysis by Value from 2019 to 2031]:
- Discovery
- Target identification
- Reverse docking
- Bioinformatics
- Protein structure prediction
- Target validation
- Lead discovery
- Pharmacophore
- Others
In-Silico Drug Discovery Market by End Use [Analysis by Value from 2019 to 2031]:
- Contract research organizations
- Pharmaceutical industry
- Academic & research institutes
- Others
In-Silico Drug Discovery Market by Region [Analysis by Value from 2019 to 2031]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the In-Silico Drug Discovery Market
In-silico drug discovery is a rapidly emerging field, leveraging AI, machine learning, and big data analytics to transform drug discovery by increasing predictive accuracy and reducing time and costs. Key developments in countries like the United States, China, Germany, India, and Japan reflect global trends of increased investment and technological innovation.
- United States: In the US, advancements in AI and machine learning have significantly improved predictive modeling and virtual screening in drug discovery. Firms are increasingly using advanced algorithms and big data on disease biology to identify potential drug candidates more accurately and quickly, promoting faster and more affordable drug development.
- China: China is focusing on integrating AI with bioinformatics to accelerate drug discovery. Sophisticated computational tools for predicting drug interactions and efficacy have been developed, advancing China's goal of becoming a global leader in pharmaceutical innovation.
- Germany: Germany is applying high-performance computing to drug discovery, supported by a strong R&D infrastructure. This helps in developing in-silico models that enhance drug target identification and optimization in drug design.
- India: India is working toward democratizing access to in-silico drug discovery tools through cloud-based platforms and partnerships with global firms, aiming to strengthen its drug development and research capabilities.
- Japan: Japan is advancing its in-silico drug discovery platform by integrating genomics and AI. The country is focused on using these technologies to support precision medicine and accelerate targeted therapy development.
Features of the Global In-Silico Drug Discovery Market
- Market Size Estimates: In-silico drug discovery market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
- Segmentation Analysis: In-silico drug discovery market size by various segments, such as by type, target therapeutic area, workflow, end use, and region in terms of value ($B).
- Regional Analysis: In-silico drug discovery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different types, target therapeutic areas, workflow, end uses, and regions for the in-silico drug discovery market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in-silico drug discovery market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
This report answers following 11 key questions:
- Q.1. What are some of the most promising, high-growth opportunities for the in-silico drug discovery market by type (software as a service, consultancy as a service, and software), target therapeutic area (human immunodeficiency virus (HIV), infectious diseases, metabolic disorders, mental disorders, musculoskeletal disorders, neurological disorders, oncological disorders, respiratory disorders, and others), workflow (discovery, target identification, reverse docking, bioinformatics, protein structure prediction, target validation, lead discovery, pharmacophore, and others), end use (contract research organizations, pharmaceutical industry, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
- Q.2. Which segments will grow at a faster pace and why?
- Q.3. Which region will grow at a faster pace and why?
- Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
- Q.5. What are the business risks and competitive threats in this market?
- Q.6. What are the emerging trends in this market and the reasons behind them?
- Q.7. What are some of the changing demands of customers in the market?
- Q.8. What are the new developments in the market? Which companies are leading these developments?
- Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
- Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
- Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Market Overview
- 2.1 Background and Classifications
- 2.2 Supply Chain
3. Market Trends & Forecast Analysis
- 3.2 Industry Drivers and Challenges
- 3.3 PESTLE Analysis
- 3.4 Patent Analysis
- 3.5 Regulatory Environment
4. Global In-Silico Drug Discovery Market by Type
- 4.1 Overview
- 4.2 Attractiveness Analysis by Type
- 4.3 Software as a service: Trends and Forecast (2019-2031)
- 4.4 Consultancy as a service: Trends and Forecast (2019-2031)
- 4.5 Software: Trends and Forecast (2019-2031)
5. Global In-Silico Drug Discovery Market by Target Therapeutic Area
- 5.1 Overview
- 5.2 Attractiveness Analysis by Target Therapeutic Area
- 5.3 Human Immunodeficiency Virus (HIV): Trends and Forecast (2019-2031)
- 5.4 Infectious diseases: Trends and Forecast (2019-2031)
- 5.5 Metabolic disorders: Trends and Forecast (2019-2031)
- 5.6 Mental disorders: Trends and Forecast (2019-2031)
- 5.7 Musculoskeletal disorders: Trends and Forecast (2019-2031)
- 5.8 Neurological disorders: Trends and Forecast (2019-2031)
- 5.9 Oncological disorders: Trends and Forecast (2019-2031)
- 5.10 Respiratory disorders: Trends and Forecast (2019-2031)
- 5.11 Others: Trends and Forecast (2019-2031)
6. Global In-Silico Drug Discovery Market by Workflow
- 6.1 Overview
- 6.2 Attractiveness Analysis by Workflow
- 6.3 Discovery: Trends and Forecast (2019-2031)
- 6.4 Target identification: Trends and Forecast (2019-2031)
- 6.5 Reverse docking: Trends and Forecast (2019-2031)
- 6.6 Bioinformatics: Trends and Forecast (2019-2031)
- 6.7 Protein structure prediction: Trends and Forecast (2019-2031)
- 6.8 Target validation: Trends and Forecast (2019-2031)
- 6.9 Lead discovery: Trends and Forecast (2019-2031)6.10 Pharmacophore: Trends and Forecast (2019-2031)6.11 Others: Trends and Forecast (2019-2031)
7. Global In-Silico Drug Discovery Market by End Use
- 7.1 Overview
- 7.2 Attractiveness Analysis by End Use
- 7.3 Contract research organizations: Trends and Forecast (2019-2031)
- 7.4 Pharmaceutical industry: Trends and Forecast (2019-2031)
- 7.5 Academic & research institutes: Trends and Forecast (2019-2031)
- 7.6 Others: Trends and Forecast (2019-2031)
8. Regional Analysis
- 8.1 Overview
- 8.2 Global In-Silico Drug Discovery Market by Region
9. North American In-Silico Drug Discovery Market
- 9.1 Overview
- 9.2 North American In-Silico Drug Discovery Market by Type
- 9.3 North American In-Silico Drug Discovery Market by End Use
- 9.4 United States In-Silico Drug Discovery Market
- 9.5 Mexican In-Silico Drug Discovery Market
- 9.6 Canadian In-Silico Drug Discovery Market
10. European In-Silico Drug Discovery Market
- 10.1 Overview
- 10.2 European In-Silico Drug Discovery Market by Type
- 10.3 European In-Silico Drug Discovery Market by End Use
- 10.4 German In-Silico Drug Discovery Market
- 10.5 French In-Silico Drug Discovery Market
- 10.6 Spanish In-Silico Drug Discovery Market
- 10.7 Italian In-Silico Drug Discovery Market
- 10.8 United Kingdom In-Silico Drug Discovery Market
11. APAC In-Silico Drug Discovery Market
- 11.1 Overview
- 11.2 APAC In-Silico Drug Discovery Market by Type
- 11.3 APAC In-Silico Drug Discovery Market by End Use
- 11.4 Japanese In-Silico Drug Discovery Market
- 11.5 Indian In-Silico Drug Discovery Market
- 11.6 Chinese In-Silico Drug Discovery Market
- 11.7 South Korean In-Silico Drug Discovery Market
- 11.8 Indonesian In-Silico Drug Discovery Market
12. ROW In-Silico Drug Discovery Market
- 12.1 Overview
- 12.2 ROW In-Silico Drug Discovery Market by Type
- 12.3 ROW In-Silico Drug Discovery Market by End Use
- 12.4 Middle Eastern In-Silico Drug Discovery Market
- 12.5 South American In-Silico Drug Discovery Market
- 12.6 African In-Silico Drug Discovery Market
13. Competitor Analysis
- 13.1 Product Portfolio Analysis
- 13.2 Operational Integration
- 13.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
- 13.4 Market Share Analysis
14. Opportunities & Strategic Analysis
- 14.1 Value Chain Analysis
- 14.2 Growth Opportunity Analysis
- 14.2.1 Growth Opportunities by Type
- 14.2.2 Growth Opportunities by Target Therapeutic Area
- 14.2.3 Growth Opportunities by Workflow
- 14.2.4 Growth Opportunities by End Use
- 14.3 Emerging Trends in the Global In-Silico Drug Discovery Market
- 14.4 Strategic Analysis
- 14.4.1 New Product Development
- 14.4.2 Certification and Licensing
- 14.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures
15. Company Profiles of the Leading Players Across the Value Chain
- 15.1 Competitive Analysis
- 15.2 Curia
- Company Overview
- In-Silico Drug Discovery Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.3 Certara
- Company Overview
- In-Silico Drug Discovery Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.4 Charles River Laboratories
- Company Overview
- In-Silico Drug Discovery Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.5 Chemical Computing
- Company Overview
- In-Silico Drug Discovery Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.6 GenScript
- Company Overview
- In-Silico Drug Discovery Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.7 Sygnature Discovery
- Company Overview
- In-Silico Drug Discovery Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.8 Abzena
- Company Overview
- In-Silico Drug Discovery Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
16. Appendix
- 16.1 List of Figures
- 16.2 List of Tables
- 16.3 Research Methodology
- 16.4 Disclaimer
- 16.5 Copyright
- 16.6 Abbreviations and Technical Units
- 16.7 About Us
- 16.8 Contact Us
List of Figures
- Figure 1.1: Trends and Forecast for the Global In-Silico Drug Discovery Market
- Figure 2.1: Usage of In-Silico Drug Discovery Market
- Figure 2.2: Classification of the Global In-Silico Drug Discovery Market
- Figure 2.3: Supply Chain of the Global In-Silico Drug Discovery Market
- Figure 3.1: Driver and Challenges of the In-Silico Drug Discovery Market
- Figure 3.2: PESTLE Analysis
- Figure 3.3: Patent Analysis
- Figure 3.4: Regulatory Environment
- Figure 4.1: Global In-Silico Drug Discovery Market by Type in 2019, 2024, and 2031
- Figure 4.2: Trends of the Global In-Silico Drug Discovery Market ($B) by Type
- Figure 4.3: Forecast for the Global In-Silico Drug Discovery Market ($B) by Type
- Figure 4.4: Trends and Forecast for Software as a service in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 4.5: Trends and Forecast for Consultancy as a service in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 4.6: Trends and Forecast for Software in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 5.1: Global In-Silico Drug Discovery Market by Target Therapeutic Area in 2019, 2024, and 2031
- Figure 5.2: Trends of the Global In-Silico Drug Discovery Market ($B) by Target Therapeutic Area
- Figure 5.3: Forecast for the Global In-Silico Drug Discovery Market ($B) by Target Therapeutic Area
- Figure 5.4: Trends and Forecast for Human Immunodeficiency Virus (HIV) in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 5.5: Trends and Forecast for Infectious diseases in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 5.6: Trends and Forecast for Metabolic disorders in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 5.7: Trends and Forecast for Mental disorders in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 5.8: Trends and Forecast for Musculoskeletal disorders in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 5.9: Trends and Forecast for Neurological disorders in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 5.10: Trends and Forecast for Oncological disorders in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 5.11: Trends and Forecast for Respiratory disorders in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 5.12: Trends and Forecast for Others in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 6.1: Global In-Silico Drug Discovery Market by Workflow in 2019, 2024, and 2031
- Figure 6.2: Trends of the Global In-Silico Drug Discovery Market ($B) by Workflow
- Figure 6.3: Forecast for the Global In-Silico Drug Discovery Market ($B) by Workflow
- Figure 6.4: Trends and Forecast for Discovery in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 6.5: Trends and Forecast for Target identification in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 6.6: Trends and Forecast for Reverse docking in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 6.7: Trends and Forecast for Bioinformatics in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 6.8: Trends and Forecast for Protein structure prediction in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 6.9: Trends and Forecast for Target validation in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 6.10: Trends and Forecast for Lead discovery in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 6.11: Trends and Forecast for Pharmacophore in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 6.12: Trends and Forecast for Others in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 7.1: Global In-Silico Drug Discovery Market by End Use in 2019, 2024, and 2031
- Figure 7.2: Trends of the Global In-Silico Drug Discovery Market ($B) by End Use
- Figure 7.3: Forecast for the Global In-Silico Drug Discovery Market ($B) by End Use
- Figure 7.4: Trends and Forecast for Contract research organizations in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 7.5: Trends and Forecast for Pharmaceutical industry in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 7.6: Trends and Forecast for Academic & research institutes in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 7.7: Trends and Forecast for Others in the Global In-Silico Drug Discovery Market (2019-2031)
- Figure 8.1: Trends of the Global In-Silico Drug Discovery Market ($B) by Region (2019-2024)
- Figure 8.2: Forecast for the Global In-Silico Drug Discovery Market ($B) by Region (2025-2031)
- Figure 9.1: North American In-Silico Drug Discovery Market by Type in 2019, 2024, and 2031
- Figure 9.2: Trends of the North American In-Silico Drug Discovery Market ($B) by Type (2019-2024)
- Figure 9.3: Forecast for the North American In-Silico Drug Discovery Market ($B) by Type (2025-2031)
- Figure 9.4: North American In-Silico Drug Discovery Market by End Use in 2019, 2024, and 2031
- Figure 9.5: Trends of the North American In-Silico Drug Discovery Market ($B) by End Use (2019-2024)
- Figure 9.6: Forecast for the North American In-Silico Drug Discovery Market ($B) by End Use (2025-2031)
- Figure 9.7: Trends and Forecast for the United States In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 9.8: Trends and Forecast for the Mexican In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 9.9: Trends and Forecast for the Canadian In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 10.1: European In-Silico Drug Discovery Market by Type in 2019, 2024, and 2031
- Figure 10.2: Trends of the European In-Silico Drug Discovery Market ($B) by Type (2019-2024)
- Figure 10.3: Forecast for the European In-Silico Drug Discovery Market ($B) by Type (2025-2031)
- Figure 10.4: European In-Silico Drug Discovery Market by End Use in 2019, 2024, and 2031
- Figure 10.5: Trends of the European In-Silico Drug Discovery Market ($B) by End Use (2019-2024)
- Figure 10.6: Forecast for the European In-Silico Drug Discovery Market ($B) by End Use (2025-2031)
- Figure 10.7: Trends and Forecast for the German In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 10.8: Trends and Forecast for the French In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 10.9: Trends and Forecast for the Spanish In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 10.10: Trends and Forecast for the Italian In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 10.11: Trends and Forecast for the United Kingdom In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 11.1: APAC In-Silico Drug Discovery Market by Type in 2019, 2024, and 2031
- Figure 11.2: Trends of the APAC In-Silico Drug Discovery Market ($B) by Type (2019-2024)
- Figure 11.3: Forecast for the APAC In-Silico Drug Discovery Market ($B) by Type (2025-2031)
- Figure 11.4: APAC In-Silico Drug Discovery Market by End Use in 2019, 2024, and 2031
- Figure 11.5: Trends of the APAC In-Silico Drug Discovery Market ($B) by End Use (2019-2024)
- Figure 11.6: Forecast for the APAC In-Silico Drug Discovery Market ($B) by End Use (2025-2031)
- Figure 11.7: Trends and Forecast for the Japanese In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 11.8: Trends and Forecast for the Indian In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 11.9: Trends and Forecast for the Chinese In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 11.10: Trends and Forecast for the South Korean In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 11.11: Trends and Forecast for the Indonesian In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 12.1: ROW In-Silico Drug Discovery Market by Type in 2019, 2024, and 2031
- Figure 12.2: Trends of the ROW In-Silico Drug Discovery Market ($B) by Type (2019-2024)
- Figure 12.3: Forecast for the ROW In-Silico Drug Discovery Market ($B) by Type (2025-2031)
- Figure 12.4: ROW In-Silico Drug Discovery Market by End Use in 2019, 2024, and 2031
- Figure 12.5: Trends of the ROW In-Silico Drug Discovery Market ($B) by End Use (2019-2024)
- Figure 12.6: Forecast for the ROW In-Silico Drug Discovery Market ($B) by End Use (2025-2031)
- Figure 12.7: Trends and Forecast for the Middle Eastern In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 12.8: Trends and Forecast for the South American In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 12.9: Trends and Forecast for the African In-Silico Drug Discovery Market ($B) (2019-2031)
- Figure 13.1: Porter's Five Forces Analysis of the Global In-Silico Drug Discovery Market
- Figure 13.2: Market Share (%) of Top Players in the Global In-Silico Drug Discovery Market (2024)
- Figure 14.1: Growth Opportunities for the Global In-Silico Drug Discovery Market by Type
- Figure 14.2: Growth Opportunities for the Global In-Silico Drug Discovery Market by Target Therapeutic Area
- Figure 14.3: Growth Opportunities for the Global In-Silico Drug Discovery Market by Workflow
- Figure 14.4: Growth Opportunities for the Global In-Silico Drug Discovery Market by End Use
- Figure 14.5: Growth Opportunities for the Global In-Silico Drug Discovery Market by Region
- Figure 14.6: Emerging Trends in the Global In-Silico Drug Discovery Market
List of Tables
- Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the In-Silico Drug Discovery Market by Type, Target Therapeutic Area, Workflow, and End Use
- Table 1.2: Attractiveness Analysis for the In-Silico Drug Discovery Market by Region
- Table 1.3: Global In-Silico Drug Discovery Market Parameters and Attributes
- Table 3.1: Trends of the Global In-Silico Drug Discovery Market (2019-2024)
- Table 3.2: Forecast for the Global In-Silico Drug Discovery Market (2025-2031)
- Table 4.1: Attractiveness Analysis for the Global In-Silico Drug Discovery Market by Type
- Table 4.2: Market Size and CAGR of Various Type in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 4.3: Market Size and CAGR of Various Type in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 4.4: Trends of Software as a service in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 4.5: Forecast for Software as a service in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 4.6: Trends of Consultancy as a service in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 4.7: Forecast for Consultancy as a service in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 4.8: Trends of Software in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 4.9: Forecast for Software in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.1: Attractiveness Analysis for the Global In-Silico Drug Discovery Market by Target Therapeutic Area
- Table 5.2: Market Size and CAGR of Various Target Therapeutic Area in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.3: Market Size and CAGR of Various Target Therapeutic Area in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.4: Trends of Human Immunodeficiency Virus (HIV) in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.5: Forecast for Human Immunodeficiency Virus (HIV) in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.6: Trends of Infectious diseases in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.7: Forecast for Infectious diseases in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.8: Trends of Metabolic disorders in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.9: Forecast for Metabolic disorders in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.10: Trends of Mental disorders in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.11: Forecast for Mental disorders in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.12: Trends of Musculoskeletal disorders in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.13: Forecast for Musculoskeletal disorders in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.14: Trends of Neurological disorders in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.15: Forecast for Neurological disorders in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.16: Trends of Oncological disorders in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.17: Forecast for Oncological disorders in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.18: Trends of Respiratory disorders in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.19: Forecast for Respiratory disorders in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 5.20: Trends of Others in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 5.21: Forecast for Others in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.1: Attractiveness Analysis for the Global In-Silico Drug Discovery Market by Workflow
- Table 6.2: Market Size and CAGR of Various Workflow in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.3: Market Size and CAGR of Various Workflow in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.4: Trends of Discovery in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.5: Forecast for Discovery in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.6: Trends of Target identification in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.7: Forecast for Target identification in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.8: Trends of Reverse docking in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.9: Forecast for Reverse docking in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.10: Trends of Bioinformatics in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.11: Forecast for Bioinformatics in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.12: Trends of Protein structure prediction in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.13: Forecast for Protein structure prediction in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.14: Trends of Target validation in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.15: Forecast for Target validation in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.16: Trends of Lead discovery in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.17: Forecast for Lead discovery in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.18: Trends of Pharmacophore in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.19: Forecast for Pharmacophore in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 6.20: Trends of Others in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 6.21: Forecast for Others in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 7.1: Attractiveness Analysis for the Global In-Silico Drug Discovery Market by End Use
- Table 7.2: Market Size and CAGR of Various End Use in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 7.3: Market Size and CAGR of Various End Use in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 7.4: Trends of Contract research organizations in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 7.5: Forecast for Contract research organizations in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 7.6: Trends of Pharmaceutical industry in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 7.7: Forecast for Pharmaceutical industry in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 7.8: Trends of Academic & research institutes in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 7.9: Forecast for Academic & research institutes in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 7.10: Trends of Others in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 7.11: Forecast for Others in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 8.1: Market Size and CAGR of Various Regions in the Global In-Silico Drug Discovery Market (2019-2024)
- Table 8.2: Market Size and CAGR of Various Regions in the Global In-Silico Drug Discovery Market (2025-2031)
- Table 9.1: Trends of the North American In-Silico Drug Discovery Market (2019-2024)
- Table 9.2: Forecast for the North American In-Silico Drug Discovery Market (2025-2031)
- Table 9.3: Market Size and CAGR of Various Type in the North American In-Silico Drug Discovery Market (2019-2024)
- Table 9.4: Market Size and CAGR of Various Type in the North American In-Silico Drug Discovery Market (2025-2031)
- Table 9.5: Market Size and CAGR of Various End Use in the North American In-Silico Drug Discovery Market (2019-2024)
- Table 9.6: Market Size and CAGR of Various End Use in the North American In-Silico Drug Discovery Market (2025-2031)
- Table 9.7: Trends and Forecast for the United States In-Silico Drug Discovery Market (2019-2031)
- Table 9.8: Trends and Forecast for the Mexican In-Silico Drug Discovery Market (2019-2031)
- Table 9.9: Trends and Forecast for the Canadian In-Silico Drug Discovery Market (2019-2031)
- Table 10.1: Trends of the European In-Silico Drug Discovery Market (2019-2024)
- Table 10.2: Forecast for the European In-Silico Drug Discovery Market (2025-2031)
- Table 10.3: Market Size and CAGR of Various Type in the European In-Silico Drug Discovery Market (2019-2024)
- Table 10.4: Market Size and CAGR of Various Type in the European In-Silico Drug Discovery Market (2025-2031)
- Table 10.5: Market Size and CAGR of Various End Use in the European In-Silico Drug Discovery Market (2019-2024)
- Table 10.6: Market Size and CAGR of Various End Use in the European In-Silico Drug Discovery Market (2025-2031)
- Table 10.7: Trends and Forecast for the German In-Silico Drug Discovery Market (2019-2031)
- Table 10.8: Trends and Forecast for the French In-Silico Drug Discovery Market (2019-2031)
- Table 10.9: Trends and Forecast for the Spanish In-Silico Drug Discovery Market (2019-2031)
- Table 10.10: Trends and Forecast for the Italian In-Silico Drug Discovery Market (2019-2031)
- Table 10.11: Trends and Forecast for the United Kingdom In-Silico Drug Discovery Market (2019-2031)
- Table 11.1: Trends of the APAC In-Silico Drug Discovery Market (2019-2024)
- Table 11.2: Forecast for the APAC In-Silico Drug Discovery Market (2025-2031)
- Table 11.3: Market Size and CAGR of Various Type in the APAC In-Silico Drug Discovery Market (2019-2024)
- Table 11.4: Market Size and CAGR of Various Type in the APAC In-Silico Drug Discovery Market (2025-2031)
- Table 11.5: Market Size and CAGR of Various End Use in the APAC In-Silico Drug Discovery Market (2019-2024)
- Table 11.6: Market Size and CAGR of Various End Use in the APAC In-Silico Drug Discovery Market (2025-2031)
- Table 11.7: Trends and Forecast for the Japanese In-Silico Drug Discovery Market (2019-2031)
- Table 11.8: Trends and Forecast for the Indian In-Silico Drug Discovery Market (2019-2031)
- Table 11.9: Trends and Forecast for the Chinese In-Silico Drug Discovery Market (2019-2031)
- Table 11.10: Trends and Forecast for the South Korean In-Silico Drug Discovery Market (2019-2031)
- Table 11.11: Trends and Forecast for the Indonesian In-Silico Drug Discovery Market (2019-2031)
- Table 12.1: Trends of the ROW In-Silico Drug Discovery Market (2019-2024)
- Table 12.2: Forecast for the ROW In-Silico Drug Discovery Market (2025-2031)
- Table 12.3: Market Size and CAGR of Various Type in the ROW In-Silico Drug Discovery Market (2019-2024)
- Table 12.4: Market Size and CAGR of Various Type in the ROW In-Silico Drug Discovery Market (2025-2031)
- Table 12.5: Market Size and CAGR of Various End Use in the ROW In-Silico Drug Discovery Market (2019-2024)
- Table 12.6: Market Size and CAGR of Various End Use in the ROW In-Silico Drug Discovery Market (2025-2031)
- Table 12.7: Trends and Forecast for the Middle Eastern In-Silico Drug Discovery Market (2019-2031)
- Table 12.8: Trends and Forecast for the South American In-Silico Drug Discovery Market (2019-2031)
- Table 12.9: Trends and Forecast for the African In-Silico Drug Discovery Market (2019-2031)
- Table 13.1: Product Mapping of In-Silico Drug Discovery Suppliers Based on Segments
- Table 13.2: Operational Integration of In-Silico Drug Discovery Manufacturers
- Table 13.3: Rankings of Suppliers Based on In-Silico Drug Discovery Revenue
- Table 14.1: New Product Launches by Major In-Silico Drug Discovery Producers (2019-2024)
- Table 14.2: Certification Acquired by Major Competitor in the Global In-Silico Drug Discovery Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.